PDE5A and breast cancer: Tinsley et al., reported that inhibition of PDE5 with sulindac sulfide (SS) caused the increase of cGMP, the activation of PKG and this in turn, the inhibition in cell growth and induction of apoptosis in breast cancer cell lines (MDA -MB-231 and SK-BR-3) (40).